Stay updated on Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.

Latest updates to the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page
- ChecktodayChange DetectedSite revision updated from v3.3.3 to v3.3.4; no user-facing content changes to the Study Details page were observed.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a Locations section with the Pittsburgh, PA site and updated the page revision to v3.3.3; removed the HHS Vulnerability Disclosure and the previous Pennsylvania Locations reference.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page shows a revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the notice about lapse in government funding and operating status from the page; this is maintenance content and does not alter the study details or data presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedThe new screenshot shows only cosmetic styling and layout adjustments; core study data and sections (Overview, Eligibility Criteria, Outcomes, and Study Record Dates) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check101 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If there are no other changes, this is the main shift.SummaryDifference5%

Stay in the know with updates to Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.